| potassium voltage-gated channel, subfamily H (eag-related), member 2 | CHLORPROMAZINE | Potassium Channel HERG | 72% | 5.8275uM | 4.7743uM | View | 
          
            
                | potassium voltage-gated channel, subfamily H (eag-related), member 5 | CHLORPROMAZINE | Potassium Channel HERG | 72% | 5.8275uM | 4.7743uM | View | 
          
            
                | potassium voltage-gated channel, subfamily H (eag-related), member 3 | CHLORPROMAZINE | Potassium Channel HERG | 72% | 5.8275uM | 4.7743uM | View | 
          
            
                | potassium voltage-gated channel, subfamily H (eag-related), member 4 | CHLORPROMAZINE | Potassium Channel HERG | 72% | 5.8275uM | 4.7743uM | View | 
          
            
                | potassium voltage-gated channel, subfamily H (eag-related), member 1 | CHLORPROMAZINE | Potassium Channel HERG | 72% | 5.8275uM | 4.7743uM | View | 
          
            
                | calcium channel, voltage-dependent, L type, alpha 1E subunit | BW-723C86 | Calcium Channel Type L, Benzothiazepine | 73% | 3.4696uM | 3.0841uM | View | 
          
            
                | calcium channel, voltage-dependent, N type, alpha 1B subunit | BW-723C86 | Calcium Channel Type L, Benzothiazepine | 73% | 3.4696uM | 3.0841uM | View | 
          
            
                | calcium channel, voltage-dependent, alpha2/delta subunit 1 | BW-723C86 | Calcium Channel Type L, Benzothiazepine | 73% | 3.4696uM | 3.0841uM | View | 
          
            
                | cholinergic receptor, muscarinic 5 | SULOCTIDIL | Muscarinic M5 | 73% | 4.4868uM | 3.2235uM | View | 
          
            
                | solute carrier family 6 (neurotransmitter transporter, serotonin), member 4 | DOMPERIDONE | Serotonin Transporter | 73% | 3.055uM | 1.623uM | View | 
          
            
                | mitogen activated protein kinase 3 | ZAFIRLUKAST | Protein Serine/Threonine Kinase, ERK1 | 73% | 4.376uM | NoneNone | View | 
          
            
                | mitogen-activated protein kinase 3 | ZAFIRLUKAST | Protein Serine/Threonine Kinase, ERK1 | 73% | 4.376uM | NoneNone | View | 
          
            
                | cholinergic receptor, muscarinic 1 | MONTELUKAST | Muscarinic M1 | 73% | 8.045uM | 1.938uM | View | 
          
            
                | cholinergic receptor, muscarinic 1 | METHAPYRILENE | Muscarinic M1 | 73% | 4.773uM | 1.15uM | View | 
          
            
                | dopamine receptor D3 | MONTELUKAST | Dopamine D3 | 73% | 7.747uM | 2.631uM | View | 
          
            
                | calcium channel, voltage-dependent, gamma subunit 8 | DESLORATADINE | Calcium Channel Type L, Benzothiazepine | 73% | 5.791uM | 5.148uM | View | 
          
            
                | calcium channel, voltage-dependent, gamma subunit 7 | DESLORATADINE | Calcium Channel Type L, Benzothiazepine | 73% | 5.791uM | 5.148uM | View | 
          
            
                | calcium channel, voltage-dependent, gamma subunit 6 | DESLORATADINE | Calcium Channel Type L, Benzothiazepine | 73% | 5.791uM | 5.148uM | View | 
          
            
                | calcium channel, voltage-dependent, gamma subunit 5 | DESLORATADINE | Calcium Channel Type L, Benzothiazepine | 73% | 5.791uM | 5.148uM | View | 
          
            
                | calcium channel, voltage-dependent, gamma subunit 4 | DESLORATADINE | Calcium Channel Type L, Benzothiazepine | 73% | 5.791uM | 5.148uM | View | 
          
            
                | calcium channel, voltage-dependent, gamma subunit 3 | DESLORATADINE | Calcium Channel Type L, Benzothiazepine | 73% | 5.791uM | 5.148uM | View | 
          
            
                | calcium channel, voltage-dependent, gamma subunit 2 | DESLORATADINE | Calcium Channel Type L, Benzothiazepine | 73% | 5.791uM | 5.148uM | View | 
          
            
                | calcium channel, voltage-dependent, gamma subunit 1 | DESLORATADINE | Calcium Channel Type L, Benzothiazepine | 73% | 5.791uM | 5.148uM | View | 
          
            
                | calcium channel, voltage-dependent, beta 4 subunit | DESLORATADINE | Calcium Channel Type L, Benzothiazepine | 73% | 5.791uM | 5.148uM | View | 
          
            
                | calcium channel, voltage-dependent, beta 3 subunit | DESLORATADINE | Calcium Channel Type L, Benzothiazepine | 73% | 5.791uM | 5.148uM | View | 
          
            
                | calcium channel, voltage-dependent, beta 2 subunit | DESLORATADINE | Calcium Channel Type L, Benzothiazepine | 73% | 5.791uM | 5.148uM | View | 
          
            
                | calcium channel, voltage-dependent, L type, alpha 1S subunit | DESLORATADINE | Calcium Channel Type L, Benzothiazepine | 73% | 5.791uM | 5.148uM | View | 
          
            
                | calcium channel, voltage-dependent, alpha 1F subunit | DESLORATADINE | Calcium Channel Type L, Benzothiazepine | 73% | 5.791uM | 5.148uM | View | 
          
            
                | calcium channel, voltage-dependent, L type, alpha 1D subunit | DESLORATADINE | Calcium Channel Type L, Benzothiazepine | 73% | 5.791uM | 5.148uM | View | 
          
            
                | calcium channel, voltage-dependent, L type, alpha 1C subunit | DESLORATADINE | Calcium Channel Type L, Benzothiazepine | 73% | 5.791uM | 5.148uM | View | 
          
            
                | calcium channel, voltage-dependent, P/Q type, alpha 1A subunit | DESLORATADINE | Calcium Channel Type L, Benzothiazepine | 73% | 5.791uM | 5.148uM | View | 
          
            
                | calcium channel, voltage-dependent, beta 1 subunit | DESLORATADINE | Calcium Channel Type L, Benzothiazepine | 73% | 5.791uM | 5.148uM | View | 
          
            
                | calcium channel, voltage-dependent, L type, alpha 1E subunit | DESLORATADINE | Calcium Channel Type L, Benzothiazepine | 73% | 5.791uM | 5.148uM | View | 
          
            
                | calcium channel, voltage-dependent, N type, alpha 1B subunit | DESLORATADINE | Calcium Channel Type L, Benzothiazepine | 73% | 5.791uM | 5.148uM | View | 
          
            
                | calcium channel, voltage-dependent, alpha2/delta subunit 1 | DESLORATADINE | Calcium Channel Type L, Benzothiazepine | 73% | 5.791uM | 5.148uM | View | 
          
            
                | Cytochrome P450, subfamily IIC (mephenytoin 4-hydroxylase) | RESVERATROL | CYP450-2C9 Inhibition | 73% | 7uM | NoneNone | View | 
          
            
                | cytochrome P450, family 2, subfamily C, polypeptide 9 | RESVERATROL | CYP450-2C9 Inhibition | 73% | 7uM | NoneNone | View | 
          
            
                | adrenergic receptor, beta 3 | ALPHA-ERGOCRYPTINE | Adrenergic beta3 | 73% | 2.496uM | 1.872uM | View | 
          
            
                | 5-hydroxytryptamine (serotonin) receptor 5B | BERBERINE CHLORIDE | Serotonin 5-HT4 | 73% | 2.222uM | .37uM | View | 
          
            
                | 5-hydroxytryptamine (serotonin) receptor 4 | BERBERINE CHLORIDE | Serotonin 5-HT4 | 73% | 2.222uM | .37uM | View | 
          
            
                | calcium channel, voltage-dependent, gamma subunit 8 | DIPHENIDOL | Calcium Channel Type L, Phenylalkylamine | 73% | 4.501uM | 4.376uM | View | 
          
            
                | calcium channel, voltage-dependent, gamma subunit 7 | DIPHENIDOL | Calcium Channel Type L, Phenylalkylamine | 73% | 4.501uM | 4.376uM | View | 
          
            
                | calcium channel, voltage-dependent, gamma subunit 6 | DIPHENIDOL | Calcium Channel Type L, Phenylalkylamine | 73% | 4.501uM | 4.376uM | View | 
          
            
                | calcium channel, voltage-dependent, gamma subunit 5 | DIPHENIDOL | Calcium Channel Type L, Phenylalkylamine | 73% | 4.501uM | 4.376uM | View | 
          
            
                | calcium channel, voltage-dependent, gamma subunit 4 | DIPHENIDOL | Calcium Channel Type L, Phenylalkylamine | 73% | 4.501uM | 4.376uM | View | 
          
            
                | calcium channel, voltage-dependent, gamma subunit 3 | DIPHENIDOL | Calcium Channel Type L, Phenylalkylamine | 73% | 4.501uM | 4.376uM | View | 
          
            
                | calcium channel, voltage-dependent, gamma subunit 2 | DIPHENIDOL | Calcium Channel Type L, Phenylalkylamine | 73% | 4.501uM | 4.376uM | View | 
          
            
                | calcium channel, voltage-dependent, gamma subunit 1 | DIPHENIDOL | Calcium Channel Type L, Phenylalkylamine | 73% | 4.501uM | 4.376uM | View | 
          
            
                | calcium channel, voltage-dependent, beta 4 subunit | DIPHENIDOL | Calcium Channel Type L, Phenylalkylamine | 73% | 4.501uM | 4.376uM | View | 
          
            
                | calcium channel, voltage-dependent, beta 3 subunit | DIPHENIDOL | Calcium Channel Type L, Phenylalkylamine | 73% | 4.501uM | 4.376uM | View | 
          
            
                | calcium channel, voltage-dependent, beta 2 subunit | DIPHENIDOL | Calcium Channel Type L, Phenylalkylamine | 73% | 4.501uM | 4.376uM | View | 
          
            
                | ATPase, Na+/K+ transporting, alpha 3 polypeptide | SODIUM ORTHOVANADATE | ATPase, Na+/K+ | 72% | 1.853uM | NoneNone | View | 
          
            
                | ATPase, Na+/K+ transporting, alpha 2 polypeptide | SODIUM ORTHOVANADATE | ATPase, Na+/K+ | 72% | 1.853uM | NoneNone | View | 
          
            
                | ATPase, Na+/K+ transporting, alpha 1 polypeptide | SODIUM ORTHOVANADATE | ATPase, Na+/K+ | 72% | 1.853uM | NoneNone | View | 
          
            
                | ATPase, Na+/K+ transporting, beta 1 polypeptide | SODIUM ORTHOVANADATE | ATPase, Na+/K+ | 72% | 1.853uM | NoneNone | View | 
          
            
                | ATPase, Na+/K+ transporting, beta 3 polypeptide | SODIUM ORTHOVANADATE | ATPase, Na+/K+ | 72% | 1.853uM | NoneNone | View | 
          
            
                | ATPase, Na+/K+ transporting, beta 2 polypeptide | SODIUM ORTHOVANADATE | ATPase, Na+/K+ | 72% | 1.853uM | NoneNone | View | 
          
            
                | ATPase, (Na+)/K+ transporting, beta 4 polypeptide | SODIUM ORTHOVANADATE | ATPase, Na+/K+ | 72% | 1.853uM | NoneNone | View | 
          
            
                | matrix metallopeptidase 9 | BUSULFAN | Protease, Matrix Metalloprotease-9 (MMP-9) | 72% | 5.215uM | NoneNone | View | 
          
            
                | matrix metalloproteinase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) | BUSULFAN | Protease, Matrix Metalloprotease-9 (MMP-9) | 72% | 5.215uM | NoneNone | View | 
          
            
                | solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2 | PROMETHAZINE | Adrenergic, Norepinephrine Transporter | 72% | 4.238uM | 4.203uM | View | 
          
            
                | 5-hydroxytryptamine (serotonin) receptor 2B | CETYLPYRIDINIUM BROMIDE | Serotonin 5-HT2B | 72% | 5.69uM | 3.621uM | View | 
          
            
                | 5-hydroxytryptamine (serotonin) receptor 2B | PHENTOLAMINE | Serotonin 5-HT2B | 72% | 3.807uM | 2.422uM | View | 
          
            
                | A3 adenosine receptor | NISOLDIPINE | Adenosine A3 | 72% | 7.12uM | 4.024uM | View | 
          
            
                | adrenergic receptor, beta 3 | ASTEMIZOLE | Adrenergic beta3 | 72% | 8.06uM | 6.045uM | View | 
          
            
                | lymphocyte protein tyrosine kinase (mapped) | ASTEMIZOLE | Protein Tyrosine Kinase, Lck | 72% | 19.92uM | NoneNone | View | 
          
            
                | 5-hydroxytryptamine receptor 6 | CLOMIPHENE | Serotonin 5-HT6 | 72% | 1.522uM | .707uM | View | 
          
            
                | adrenergic receptor, alpha 1b | CLOMIPHENE | Adrenergic alpha1B | 72% | 4.569uM | 2.529uM | View | 
          
            
                | cholinergic receptor, muscarinic 4 | DROPERIDOL | Muscarinic M4 | 72% | 3.849uM | .537uM | View | 
          
            
                | 5-hydroxytryptamine (serotonin) receptor 2B | DROPERIDOL | Serotonin 5-HT2B | 72% | 1.342uM | .854uM | View | 
          
            
                | sodium channel, voltage-gated, type I, beta | DIHYDROERGOTAMINE | Sodium Channel, Site 2 | 72% | 5.058uM | 4.614uM | View | 
          
            
                | sodium channel, voltage-gated, type 10, alpha polypeptide | DIHYDROERGOTAMINE | Sodium Channel, Site 2 | 72% | 5.058uM | 4.614uM | View | 
          
            
                | sodium channel, voltage-gated, type IV, alpha polypeptide | DIHYDROERGOTAMINE | Sodium Channel, Site 2 | 72% | 5.058uM | 4.614uM | View | 
          
            
                | sodium channel, voltage-gated, type V, alpha polypeptide | DIHYDROERGOTAMINE | Sodium Channel, Site 2 | 72% | 5.058uM | 4.614uM | View | 
          
            
                | sodium channel, voltage-gated, type II, beta | DIHYDROERGOTAMINE | Sodium Channel, Site 2 | 72% | 5.058uM | 4.614uM | View | 
          
            
                | sodium channel, nonvoltage-gated 1 alpha | DIHYDROERGOTAMINE | Sodium Channel, Site 2 | 72% | 5.058uM | 4.614uM | View | 
          
            
                | sodium channel, nonvoltage-gated 1 gamma | DIHYDROERGOTAMINE | Sodium Channel, Site 2 | 72% | 5.058uM | 4.614uM | View | 
          
            
                | sodium channel, nonvoltage-gated 1 beta | DIHYDROERGOTAMINE | Sodium Channel, Site 2 | 72% | 5.058uM | 4.614uM | View | 
          
            
                | sodium channel, voltage-gated, type 2, alpha 1 polypeptide | DIHYDROERGOTAMINE | Sodium Channel, Site 2 | 72% | 5.058uM | 4.614uM | View | 
          
            
                | sodium channel, voltage-gated, type XI, alpha | DIHYDROERGOTAMINE | Sodium Channel, Site 2 | 72% | 5.058uM | 4.614uM | View | 
          
            
                | sodium channel, nonvoltage-gated 1, gamma | DIHYDROERGOTAMINE | Sodium Channel, Site 2 | 72% | 5.058uM | 4.614uM | View | 
          
            
                | sodium channel, nonvoltage-gated 1, delta | DIHYDROERGOTAMINE | Sodium Channel, Site 2 | 72% | 5.058uM | 4.614uM | View | 
          
            
                | sodium channel, nonvoltage-gated 1, beta (Liddle syndrome) | DIHYDROERGOTAMINE | Sodium Channel, Site 2 | 72% | 5.058uM | 4.614uM | View | 
          
            
                | sodium channel, nonvoltage-gated 1 alpha | DIHYDROERGOTAMINE | Sodium Channel, Site 2 | 72% | 5.058uM | 4.614uM | View | 
          
            
                | sodium channel, voltage-gated, type X, alpha | DIHYDROERGOTAMINE | Sodium Channel, Site 2 | 72% | 5.058uM | 4.614uM | View | 
          
            
                | sodium channel, voltage-gated, type IX, alpha | DIHYDROERGOTAMINE | Sodium Channel, Site 2 | 72% | 5.058uM | 4.614uM | View | 
          
            
                | sodium channel, voltage gated, type VIII, alpha | DIHYDROERGOTAMINE | Sodium Channel, Site 2 | 72% | 5.058uM | 4.614uM | View | 
          
            
                | sodium channel, voltage-gated, type VII, alpha | DIHYDROERGOTAMINE | Sodium Channel, Site 2 | 72% | 5.058uM | 4.614uM | View | 
          
            
                | adrenergic receptor, alpha 2a | YOHIMBINE | Imidazoline I2, Central | 72% | .157uM | .105uM | View | 
          
            
                | adrenergic receptor, alpha 2c (Non-specific probe) | YOHIMBINE | Imidazoline I2, Central | 72% | .157uM | .105uM | View | 
          
            
                | adrenergic receptor, beta 1 | TAMOXIFEN | Adrenergic beta1 | 72% | 17.289uM | 9.984uM | View | 
          
            
                | adrenergic, beta-1-, receptor | TAMOXIFEN | Adrenergic beta1 | 72% | 17.289uM | 9.984uM | View | 
          
            
                | solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 | CLOMIPRAMINE | Dopamine Transporter | 72% | 2.746uM | 2.182uM | View | 
          
            
                | adrenergic receptor, alpha 2b | METHAPYRILENE | Adrenergic alpha2B | 72% | 3.318uM | 1.515uM | View | 
          
            
                | 5-hydroxytryptamine (serotonin) receptor 2A | TETRACAINE | Serotonin 5-HT2A | 72% | 3.415uM | .976uM | View | 
          
            
                | cholinergic receptor, muscarinic 3 | FLUOXETINE | Muscarinic M3 | 72% | 3.595uM | .762uM | View | 
          
            
                | Sigma-2 Receptor | FLUPHENAZINE | Sigma2 | 72% | .158uM | .097uM | View | 
          
            
                | Cytochrom P450-1A2 monooxygenase | SULINDAC SULFIDE | CYP450-1A2 Inhibition | 72% | 2uM | NoneNone | View | 
          
            
                | Cytochrom P450-1A2 monooxygenase | NABUMETONE | CYP450-1A2 Inhibition | 72% | 5uM | NoneNone | View | 
          
            
                | opioid receptor, sigma 1 | R-(+)-PROPRANOLOL | Sigma1 | 72% | 3.974uM | 1.67uM | View | 
          
            
                | solute carrier family 6 (neurotransmitter transporter, serotonin), member 4 | HALOPERIDOL | Serotonin Transporter | 72% | 3.386uM | 1.799uM | View | 
          
            
                | 5-hydroxytryptamine (serotonin) receptor 1A | R-(+)-PROPRANOLOL | Serotonin 5-HT1A | 72% | 4.88uM | 2.789uM | View | 
          
            
                | dopamine receptor D1A | LYSERGOL | Dopamine D1 | 72% | 2.908uM | 1.454uM | View | 
          
            
                | adrenergic receptor, alpha 1d (Non-specific probe) | LYSERGOL | Adrenergic alpha1D | 72% | 1.128uM | .554uM | View | 
          
            
                | adrenergic receptor, alpha 2a | METHYSERGIDE | Imidazoline I2, Central | 72% | 2.519uM | 1.68uM | View | 
          
            
                | adrenergic receptor, alpha 2c (Non-specific probe) | METHYSERGIDE | Imidazoline I2, Central | 72% | 2.519uM | 1.68uM | View | 
          
            
                | potassium voltage-gated channel, subfamily H (eag-related), member 1 | CHLORPROMAZINE | Potassium Channel HERG | 72% | 5.8275uM | 4.7743uM | View | 
          
            
                | potassium voltage-gated channel, subfamily H, member 8 | VERAPAMIL | Potassium Channel HERG | 72% | NoneNone | NoneNone | View | 
          
            
                | potassium voltage-gated channel, subfamily H (eag-related), member 6 | VERAPAMIL | Potassium Channel HERG | 72% | NoneNone | NoneNone | View | 
          
            
                | potassium voltage-gated channel, subfamily H (eag-related), member 7 | VERAPAMIL | Potassium Channel HERG | 72% | NoneNone | NoneNone | View | 
          
            
                | potassium voltage-gated channel, subfamily H (eag-related), member 2 | VERAPAMIL | Potassium Channel HERG | 72% | NoneNone | NoneNone | View | 
          
            
                | potassium voltage-gated channel, subfamily H (eag-related), member 5 | VERAPAMIL | Potassium Channel HERG | 72% | NoneNone | NoneNone | View | 
          
            
                | potassium voltage-gated channel, subfamily H (eag-related), member 3 | VERAPAMIL | Potassium Channel HERG | 72% | NoneNone | NoneNone | View | 
          
            
                | potassium voltage-gated channel, subfamily H (eag-related), member 4 | VERAPAMIL | Potassium Channel HERG | 72% | NoneNone | NoneNone | View | 
          
            
                | potassium voltage-gated channel, subfamily H (eag-related), member 1 | VERAPAMIL | Potassium Channel HERG | 72% | NoneNone | NoneNone | View | 
          
            
                | potassium voltage-gated channel, subfamily H (eag-related), member 1 | VERAPAMIL | Potassium Channel HERG | 72% | NoneNone | NoneNone | View | 
          
            
                | androgen receptor | ZINC CHLORIDE | Testosterone | 72% | 6.5086uM | 4.3391uM | View | 
          
            
                | 5-hydroxytryptamine (serotonin) receptor 2B | HEXACHLOROPHENE | Serotonin 5-HT2B | 72% | 5.6947uM | 3.6239uM | View | 
          
            
                | mitogen activated protein kinase 14 | NAFENOPIN | Protein Serine/Threonine Kinase, p38alpha | 72% | 3.7405uM | NoneNone | View | 
          
            
                | mitogen-activated protein kinase 14 | NAFENOPIN | Protein Serine/Threonine Kinase, p38alpha | 72% | 3.7405uM | NoneNone | View | 
          
            
                | cholinergic receptor, muscarinic 1 | SULOCTIDIL | Muscarinic M1 | 72% | 4.505uM | 1.085uM | View | 
          
            
                | Cytochrom P450-1A2 monooxygenase | THIORIDAZINE | CYP450-1A2 Inhibition | 72% | 9.3323uM | NoneNone | View | 
          
            
                | Sigma-2 Receptor | TOLPERISONE | Sigma2 | 72% | 3.357uM | 2.066uM | View | 
          
            
                | 5-hydroxytryptamine (serotonin) receptor 1A | FLUNARIZINE | Serotonin 5-HT1A | 72% | 4.281uM | 2.446uM | View | 
          
            
                | 5-hydroxytryptamine (serotonin) receptor 1A | LEVOBUNOLOL | Serotonin 5-HT1A | 72% | 2.901uM | 1.658uM | View | 
          
            
                | calcium channel, voltage-dependent, gamma subunit 8 | CYCLIZINE | Calcium Channel Type L, Phenylalkylamine | 72% | 4.644uM | 4.515uM | View | 
          
            
                | calcium channel, voltage-dependent, gamma subunit 7 | CYCLIZINE | Calcium Channel Type L, Phenylalkylamine | 72% | 4.644uM | 4.515uM | View | 
          
            
                | calcium channel, voltage-dependent, gamma subunit 6 | CYCLIZINE | Calcium Channel Type L, Phenylalkylamine | 72% | 4.644uM | 4.515uM | View | 
          
            
                | calcium channel, voltage-dependent, gamma subunit 5 | CYCLIZINE | Calcium Channel Type L, Phenylalkylamine | 72% | 4.644uM | 4.515uM | View | 
          
            
                | calcium channel, voltage-dependent, gamma subunit 4 | CYCLIZINE | Calcium Channel Type L, Phenylalkylamine | 72% | 4.644uM | 4.515uM | View | 
          
            
                | calcium channel, voltage-dependent, gamma subunit 3 | CYCLIZINE | Calcium Channel Type L, Phenylalkylamine | 72% | 4.644uM | 4.515uM | View | 
          
            
                | calcium channel, voltage-dependent, gamma subunit 2 | CYCLIZINE | Calcium Channel Type L, Phenylalkylamine | 72% | 4.644uM | 4.515uM | View | 
          
            
                | calcium channel, voltage-dependent, gamma subunit 1 | CYCLIZINE | Calcium Channel Type L, Phenylalkylamine | 72% | 4.644uM | 4.515uM | View | 
          
            
                | calcium channel, voltage-dependent, beta 4 subunit | CYCLIZINE | Calcium Channel Type L, Phenylalkylamine | 72% | 4.644uM | 4.515uM | View | 
          
            
                | calcium channel, voltage-dependent, beta 3 subunit | CYCLIZINE | Calcium Channel Type L, Phenylalkylamine | 72% | 4.644uM | 4.515uM | View | 
          
            
                | calcium channel, voltage-dependent, beta 2 subunit | CYCLIZINE | Calcium Channel Type L, Phenylalkylamine | 72% | 4.644uM | 4.515uM | View | 
          
            
                | calcium channel, voltage-dependent, L type, alpha 1S subunit | CYCLIZINE | Calcium Channel Type L, Phenylalkylamine | 72% | 4.644uM | 4.515uM | View | 
          
            
                | calcium channel, voltage-dependent, alpha 1F subunit | CYCLIZINE | Calcium Channel Type L, Phenylalkylamine | 72% | 4.644uM | 4.515uM | View | 
          
            
                | calcium channel, voltage-dependent, L type, alpha 1D subunit | CYCLIZINE | Calcium Channel Type L, Phenylalkylamine | 72% | 4.644uM | 4.515uM | View | 
          
            
                | calcium channel, voltage-dependent, L type, alpha 1C subunit | CYCLIZINE | Calcium Channel Type L, Phenylalkylamine | 72% | 4.644uM | 4.515uM | View | 
          
            
                | calcium channel, voltage-dependent, P/Q type, alpha 1A subunit | CYCLIZINE | Calcium Channel Type L, Phenylalkylamine | 72% | 4.644uM | 4.515uM | View | 
          
            
                | calcium channel, voltage-dependent, beta 1 subunit | CYCLIZINE | Calcium Channel Type L, Phenylalkylamine | 72% | 4.644uM | 4.515uM | View | 
          
            
                | calcium channel, voltage-dependent, L type, alpha 1E subunit | CYCLIZINE | Calcium Channel Type L, Phenylalkylamine | 72% | 4.644uM | 4.515uM | View | 
          
            
                | calcium channel, voltage-dependent, N type, alpha 1B subunit | CYCLIZINE | Calcium Channel Type L, Phenylalkylamine | 72% | 4.644uM | 4.515uM | View | 
          
            
                | calcium channel, voltage-dependent, alpha2/delta subunit 1 | CYCLIZINE | Calcium Channel Type L, Phenylalkylamine | 72% | 4.644uM | 4.515uM | View | 
          
            
                | cytochrome P450, family 3, subfamily a, polypeptide 13 | RWJ-68354 | CYP450-3A4 Inhibition | 72% | 1uM | NoneNone | View | 
          
            
                | Cytochrom P450-2D6 monooxygenase | TRIHEXYPHENIDYL | CYP450-2D6 Inhibition | 72% | 2.4498uM | NoneNone | View | 
          
            
                | Cytochrom P450-2D6 monooxygenase | NALOXONE | CYP450-2D6 Inhibition | 72% | 2uM | NoneNone | View | 
          
            
                | Cytochrom P450-2C19 monooxygenase | SPIRONOLACTONE | CYP450-2C19 Inhibition | 72% | 3uM | NoneNone | View | 
          
            
                | 5-hydroxytryptamine (serotonin) receptor 2C | BITHIONOL | Serotonin 5-HT2C | 72% | 8.78uM | 4.599uM | View | 
          
            
                | dopamine receptor D3 | DIPHENIDOL | Dopamine D3 | 72% | 2.311uM | .785uM | View | 
          
            
                | dopamine receptor D3 | DOBUTAMINE | Dopamine D3 | 72% | 4.985uM | 1.693uM | View | 
          
            
                | adrenergic receptor, alpha 2b | CLOSANTEL | Adrenergic alpha2C | 72% | 7.1uM | 1uM | View | 
          
            
                | adrenergic receptor, alpha 2c (Non-specific probe) | CLOSANTEL | Adrenergic alpha2C | 72% | 7.1uM | 1uM | View | 
          
            
                | solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 | CLOSANTEL | Dopamine Transporter | 72% | 4.8uM | 3.8uM | View | 
          
            
                | opioid receptor, sigma 1 | DOBUTAMINE | Sigma1 | 72% | 2.518uM | 1.058uM | View | 
          
            
                | lymphocyte protein tyrosine kinase (mapped) | DOBUTAMINE | Protein Tyrosine Kinase, Lck | 72% | 5.519uM | NoneNone | View | 
          
            
                | phosphodiesterase 4A, cAMP specific | CELECOXIB | Phosphodiesterase PDE4 | 68% | 9.26uM | NoneNone | View | 
          
            
                | Sigma-2 Receptor | AMITRIPTYLINE | Sigma2 | 68% | NoneNone | NoneNone | View | 
          
            
                | calcium channel, voltage-dependent, gamma subunit 8 | AMOXAPINE | Calcium Channel Type L, Benzothiazepine | 68% | NoneNone | NoneNone | View | 
          
            
                | calcium channel, voltage-dependent, gamma subunit 7 | AMOXAPINE | Calcium Channel Type L, Benzothiazepine | 68% | NoneNone | NoneNone | View | 
          
            
                | calcium channel, voltage-dependent, gamma subunit 6 | AMOXAPINE | Calcium Channel Type L, Benzothiazepine | 68% | NoneNone | NoneNone | View | 
          
            
                | calcium channel, voltage-dependent, gamma subunit 5 | AMOXAPINE | Calcium Channel Type L, Benzothiazepine | 68% | NoneNone | NoneNone | View | 
          
            
                | calcium channel, voltage-dependent, gamma subunit 4 | AMOXAPINE | Calcium Channel Type L, Benzothiazepine | 68% | NoneNone | NoneNone | View | 
          
            
                | calcium channel, voltage-dependent, gamma subunit 3 | AMOXAPINE | Calcium Channel Type L, Benzothiazepine | 68% | NoneNone | NoneNone | View | 
          
            
                | calcium channel, voltage-dependent, gamma subunit 2 | AMOXAPINE | Calcium Channel Type L, Benzothiazepine | 68% | NoneNone | NoneNone | View | 
          
            
                | calcium channel, voltage-dependent, gamma subunit 1 | AMOXAPINE | Calcium Channel Type L, Benzothiazepine | 68% | NoneNone | NoneNone | View | 
          
            
                | calcium channel, voltage-dependent, beta 4 subunit | AMOXAPINE | Calcium Channel Type L, Benzothiazepine | 68% | NoneNone | NoneNone | View | 
          
            
                | calcium channel, voltage-dependent, beta 3 subunit | AMOXAPINE | Calcium Channel Type L, Benzothiazepine | 68% | NoneNone | NoneNone | View | 
          
            
                | calcium channel, voltage-dependent, beta 2 subunit | AMOXAPINE | Calcium Channel Type L, Benzothiazepine | 68% | NoneNone | NoneNone | View | 
          
            
                | calcium channel, voltage-dependent, L type, alpha 1S subunit | AMOXAPINE | Calcium Channel Type L, Benzothiazepine | 68% | NoneNone | NoneNone | View | 
          
            
                | calcium channel, voltage-dependent, alpha 1F subunit | AMOXAPINE | Calcium Channel Type L, Benzothiazepine | 68% | NoneNone | NoneNone | View | 
          
            
                | calcium channel, voltage-dependent, L type, alpha 1D subunit | AMOXAPINE | Calcium Channel Type L, Benzothiazepine | 68% | NoneNone | NoneNone | View | 
          
            
                | calcium channel, voltage-dependent, L type, alpha 1C subunit | AMOXAPINE | Calcium Channel Type L, Benzothiazepine | 68% | NoneNone | NoneNone | View | 
          
            
                | calcium channel, voltage-dependent, P/Q type, alpha 1A subunit | AMOXAPINE | Calcium Channel Type L, Benzothiazepine | 68% | NoneNone | NoneNone | View | 
          
            
                | calcium channel, voltage-dependent, beta 1 subunit | AMOXAPINE | Calcium Channel Type L, Benzothiazepine | 68% | NoneNone | NoneNone | View | 
          
            
                | calcium channel, voltage-dependent, L type, alpha 1E subunit | AMOXAPINE | Calcium Channel Type L, Benzothiazepine | 68% | NoneNone | NoneNone | View | 
          
            
                | calcium channel, voltage-dependent, N type, alpha 1B subunit | AMOXAPINE | Calcium Channel Type L, Benzothiazepine | 68% | NoneNone | NoneNone | View | 
          
            
                | calcium channel, voltage-dependent, alpha2/delta subunit 1 | AMOXAPINE | Calcium Channel Type L, Benzothiazepine | 68% | NoneNone | NoneNone | View | 
          
            
                | adrenergic receptor, alpha 2a | AMIODARONE | Imidazoline I2, Central | 68% | 7.826uM | 5.217uM | View | 
          
            
                | adrenergic receptor, alpha 2c (Non-specific probe) | AMIODARONE | Imidazoline I2, Central | 68% | 7.826uM | 5.217uM | View | 
          
            
                | Cytochrom P450-1A2 monooxygenase | CHLORPROMAZINE | CYP450-1A2 Inhibition | 68% | NoneNone | NoneNone | View | 
          
            
                | Cytochrome P450, subfamily IIC (mephenytoin 4-hydroxylase) | 1-BENZYLIMIDAZOLE | CYP450-2C9 Inhibition | 68% | NoneNone | NoneNone | View | 
          
            
                | cytochrome P450, family 2, subfamily C, polypeptide 9 | 1-BENZYLIMIDAZOLE | CYP450-2C9 Inhibition | 68% | NoneNone | NoneNone | View | 
          
            
                | A3 adenosine receptor | NIFEDIPINE | Adenosine A3 | 68% | 7.214uM | 4.078uM | View | 
          
            
                | mu-opioid receptor MOR | CISAPRIDE | Opiate mu | 68% | NoneNone | NoneNone | View | 
          
            
                | cytochrome P450, family 3, subfamily a, polypeptide 13 | PAPAVERINE | CYP450-3A4 Inhibition | 68% | NoneNone | NoneNone | View | 
          
            
                | Sigma-2 Receptor | PERHEXILINE | Sigma2 | 68% | NoneNone | NoneNone | View | 
          
            
                | cholinergic receptor, muscarinic 3 | HEXACHLOROPHENE | Muscarinic M3 | 68% | NoneNone | NoneNone | View | 
          
            
                | cytochrome P450, family 3, subfamily a, polypeptide 13 | HEXACHLOROPHENE | CYP450-3A4 Inhibition | 68% | NoneNone | NoneNone | View | 
          
            
                | Cytochrom P450-2C19 monooxygenase | PROPAFENONE | CYP450-2C19 Inhibition | 68% | NoneNone | NoneNone | View | 
          
            
                | matrix metallopeptidase 9 | MESNA | Protease, Matrix Metalloprotease-9 (MMP-9) | 68% | NoneNone | NoneNone | View | 
          
            
                | matrix metalloproteinase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) | MESNA | Protease, Matrix Metalloprotease-9 (MMP-9) | 68% | NoneNone | NoneNone | View | 
          
            
                | dopamine receptor D4 | 1,3-DIPHENYLGUANIDINE | Dopamine D4.2 | 68% | NoneNone | NoneNone | View | 
          
            
                | dopamine receptor 2 | DESLORATADINE | Dopamine D2L | 68% | NoneNone | NoneNone | View | 
          
            
                | Cytochrom P450-2D6 monooxygenase | MONOBENZONE | CYP450-2D6 Inhibition | 68% | NoneNone | NoneNone | View | 
          
            
                | Cytochrom P450-2D6 monooxygenase | NALOXONAZINE | CYP450-2D6 Inhibition | 68% | NoneNone | NoneNone | View | 
          
            
                | arachidonate 15-lipoxygenase, second type | RIFAPENTINE | Lipoxygenase 15-LO | 68% | NoneNone | NoneNone | View | 
          
            
                | arachidonate 15-lipoxygenase | RIFAPENTINE | Lipoxygenase 15-LO | 68% | NoneNone | NoneNone | View | 
          
            
                | arachidonate 15-lipoxygenase | RIFAPENTINE | Lipoxygenase 15-LO | 68% | NoneNone | NoneNone | View |